Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q3)Jan 31, 2026 | (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 29.93%-206.78K | 39.89%-175.18K | -7.92%-167.22K | -9.38%-966.17K | -59.70%-224.7K | -33.12%-295.12K | -33.96%-291.42K | 48.93%-154.94K | -61.06%-883.31K | -2.26%-140.7K |
| Net income from continuing operations | 79.83%-212.5K | 18.08%-191.67K | -100.22%-2.76K | 30.94%-626.78K | -340.68%-574.84K | -292.77%-1.05M | -37.44%-233.98K | 464.73%1.24M | 78.61%-907.6K | 96.43%-130.45K |
| Operating gains losses | -85.25%106.95K | -8,428.46%-102.44K | 94.34%-79.97K | -6,230.92%-527.62K | 1,655.17%158.75K | 86,966.39%725.26K | 47.66%1.23K | -679,361.54%-1.41M | -217.65%-8.33K | -1,733.28%-10.21K |
| Depreciation and amortization | -78.59%2.34K | -78.05%2.34K | -77.26%2.34K | -18.91%34.08K | -76.50%2.24K | 13.79%10.92K | -6.99%10.65K | -10.21%10.28K | -3.91%42.03K | -10.66%9.54K |
| Securities amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | 146.01%76.69K | ---- | ---- | ---- | ---- | -104.88%-166.69K | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---106.95K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | -74.97%12.97K | -33.93%15.22K | -15.75%29.59K | -68.41%142.89K | -42.08%32.92K | -30.74%51.8K | -80.34%23.04K | -82.74%35.12K | 3,985.67%452.37K | --56.84K |
| Other non cashItems | ---- | ---- | ---- | 94.17%-9.8K | --0 | 113.12%3.13K | 100.80%964 | 38.95%-13.89K | -555.68%-168.14K | -104.79%-653 |
| Change In working capital | -214.58%-9.58K | 94.02%-5.58K | -4.97%-9.47K | 56.17%-55.63K | -50.71%49.74K | 79.56%-3.05K | -67.09%-93.31K | 94.26%-9.02K | -178.33%-126.93K | 30.09%100.91K |
| -Change in receivables | 67.70%-4.02K | -152.67%-3.97K | -129.67%-17.87K | 205.68%69.87K | 270.51%14.54K | 27.03%-12.43K | 125.54%7.53K | 644.33%60.23K | -244.99%-66.11K | -280.42%-8.53K |
| -Change in prepaid assets | -198.00%-5.44K | 62.80%-279 | 73.34%-277 | 262.85%10.32K | -92.49%6.56K | -81.51%5.55K | -102.22%-750 | 99.34%-1.04K | -157.35%-6.34K | 1,646.57%87.35K |
| -Change in payables and accrued expense | -103.41%-131 | 98.67%-1.33K | 112.73%8.68K | -149.29%-135.82K | 29.61%28.64K | 113.79%3.84K | -66.31%-100.09K | -694.47%-68.21K | -151.69%-54.48K | -70.47%22.09K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 29.93%-206.78K | 39.89%-175.18K | -7.92%-167.22K | -9.38%-966.17K | -59.70%-224.7K | -33.12%-295.12K | -33.96%-291.42K | 48.93%-154.94K | -61.06%-883.31K | -2.26%-140.7K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 28.14%-301.51K | 139.58%74.77K | -140.19%-645.79K | 147.59%575.7K | -163.93%-422.52K | -37.28%-419.56K | 65.54%-188.91K | 920.66%1.61M | -12.86%-1.21M | -217.66%-160.09K |
| Net PPE purchase and sale | 293.57%1.23M | -383.61%-1.23M | --0 | 33,624.97%1.73M | 204.15%2.11K | -54.96%312.35K | 63.51%-254.19K | --1.67M | -23.29%-5.17K | ---2.02K |
| Net investment purchase and sale | --0 | --320.94K | --337.35K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other investing changes | ---- | ---- | -1,406.02%-983.13K | 3.98%-1.16M | -168.64%-424.63K | ---- | ---- | 66.66%-65.28K | -12.82%-1.2M | -216.17%-158.07K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 28.14%-301.51K | 139.58%74.77K | -140.19%-645.79K | 147.59%575.7K | -163.93%-422.52K | -37.28%-419.56K | 65.54%-188.91K | 920.66%1.61M | -12.86%-1.21M | -217.66%-160.09K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 883.22%129.6K | 0 | 0 | -32.84%1.51M | 0 | -55.55%-16.55K | 5,266.00%2.1M | -124.73%-571.76K | 161.83%2.25M | -116.22%-11.08K |
| Net issuance payments of debt | --0 | --0 | --0 | -713.64%-593.93K | --0 | -4.17%-11.08K | 72.73%-11.08K | -5,274.73%-571.76K | -71.55%-73K | -4.17%-11.08K |
| Net common stock issuance | ---- | ---- | ---- | -9.24%2.2M | --0 | --0 | --2.2M | --0 | 190.29%2.42M | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | 5.84%-95.02K | --0 | ---5.47K | ---- | ---- | -428.02%-100.92K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 883.22%129.6K | --0 | --0 | -32.84%1.51M | --0 | -55.55%-16.55K | 5,266.00%2.1M | -124.73%-571.76K | 161.83%2.25M | -116.22%-11.08K |
| Net cash flow | ||||||||||
| Beginning cash position | -78.28%635.74K | -43.74%736.14K | 261.47%1.55M | 57.84%428.56K | 196.63%2.2M | 129.01%2.93M | -37.23%1.31M | 57.84%428.56K | -73.70%271.51K | 261.71%740.44K |
| Current changes in cash | 48.21%-378.69K | -106.20%-100.41K | -192.39%-813K | 613.52%1.12M | -107.52%-647.22K | -35.93%-731.22K | 300.78%1.62M | -51.47%879.99K | 120.64%157.05K | -566.83%-311.88K |
| End cash Position | -88.30%257.05K | -78.28%635.74K | -43.74%736.14K | 261.47%1.55M | 261.47%1.55M | 196.63%2.2M | 129.01%2.93M | -37.23%1.31M | 57.84%428.56K | 57.84%428.56K |
| Free cash from | 1,818.23%1.02M | -157.70%-1.4M | -6.62%-167.22K | -10.74%-983.94K | -55.95%-222.59K | -112.61%-59.51K | 40.38%-545K | 48.30%-156.84K | -60.77%-888.47K | -3.73%-142.73K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.